Clinical Trial

Home Based Infusions for Ocrelizumab

Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated June 10, 2021 (before its estimated August 31, 2021 completion). Its status may not reflect the trial's current state.
Summary
The goal is to assess the safety and effectiveness of home ocrelizumab infusion.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2020-12-01; most recent amendment 2022-12-14.
Status change: Recruiting → Completed 2022-12-14
Status change: Not Yet Recruiting → Recruiting 2021-04-27
Trial Details
NCT Number NCT04650321
Lead Sponsor University of Colorado, Denver
Collaborators: Genentech, Inc.
Conditions Multiple Sclerosis
Enrollment 110 participants
Start Date 2021-03-01
Primary Completion 2021-08-31 (estimated)
Study Completion 2021-08-31 (estimated)
Updated on ClinicalTrials.gov 2021-06-10